AVNS Avanos Medical Inc

  1. Stocks
  2. Healthcare
  3. NYSE: AVNS

Price (delayed)

$18.18

Market cap

$839.97M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.32

Enterprise value

$961.37M

Avanos Medical, Inc. is a medical technology company focused on delivering clinical medical device solutions. The company consists of two franchises – Pain Management and Chronic Care – that address ...

Highlights
Avanos Medical's debt has decreased by 32% from the previous quarter and by 25% YoY
The quick ratio has declined by 37% year-on-year and by 34% since the previous quarter
The EPS has contracted by 12% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: https://avanos.com/
Peers: STE SYK

Key stats

What are the main financial stats of AVNS
Market
Shares outstanding
46.2M
Market cap
$839.97M
Enterprise value
$961.37M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.68
Price to sales (P/S)
1.25
EV/EBIT
N/A
EV/EBITDA
739.52
EV/Sales
1.43
Earnings
Revenue
$673.3M
EBIT
-$44.8M
EBITDA
$1.3M
Free cash flow
$14.6M
Per share
EPS
-$1.32
Free cash flow per share
$0.31
Book value per share
$26.63
Revenue per share
$14.5
TBVPS
$14.15
Balance sheet
Total assets
$1.69B
Total liabilities
$456.1M
Debt
$209.1M
Equity
$1.24B
Working capital
$252.4M
Liquidity
Debt to equity
0.17
Current ratio
2.08
Quick ratio
0.98
Net debt/EBITDA
93.38
Margins
EBITDA margin
0.2%
Gross margin
56.4%
Net margin
-9.2%
Operating margin
2.6%
Efficiency
Return on assets
-3.6%
Return on equity
-5%
Return on invested capital
-6.8%
Return on capital employed
-3.1%
Return on sales
-6.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AVNS stock price

How has the Avanos Medical stock price performed over time
Intraday
1.85%
1 week
-2.83%
1 month
-7.2%
1 year
-37.93%
YTD
-18.95%
QTD
-8.69%

Financial performance

How have Avanos Medical's revenue and profit performed over time
Revenue
$673.3M
Gross profit
$379.7M
Operating income
$17.5M
Net income
-$61.8M
Gross margin
56.4%
Net margin
-9.2%
The operating income has shrunk by 55% YoY and by 41% QoQ
Avanos Medical's operating margin has plunged by 54% YoY and by 37% from the previous quarter
Avanos Medical's net margin has decreased by 18% from the previous quarter
The net income has decreased by 12% from the previous quarter

Growth

What is Avanos Medical's growth rate over time

Valuation

What is Avanos Medical stock price valuation
AVNS P/E details
P/E
N/A
P/B
0.68
P/S
1.25
EV/EBIT
N/A
EV/EBITDA
739.52
EV/Sales
1.43
The EPS has contracted by 12% from the previous quarter
AVNS's price to book (P/B) is 44% less than its 5-year quarterly average of 1.2 and 26% less than its last 4 quarters average of 0.9
The company's equity fell by 4.3% YoY
The P/S is 44% lower than the 5-year quarterly average of 2.2 and 23% lower than the last 4 quarters average of 1.6
The revenue has declined by 6% since the previous quarter

Efficiency

How efficient is Avanos Medical business performance
AVNS's ROIC has plunged by 175% YoY and by 58% from the previous quarter
The ROS has plunged by 170% YoY and by 56% from the previous quarter
The ROE has contracted by 14% from the previous quarter
The return on assets has declined by 13% since the previous quarter

Dividends

What is AVNS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AVNS.

Financial health

How did Avanos Medical financials performed over time
The quick ratio has declined by 37% year-on-year and by 34% since the previous quarter
The company's current ratio fell by 36% YoY and by 32% QoQ
Avanos Medical's debt is 83% less than its equity
The debt to equity has contracted by 32% from the previous quarter and by 19% YoY
Avanos Medical's debt has decreased by 32% from the previous quarter and by 25% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.